Rivabiotec provides analytical insight, project structuring, and scientific coordination for research teams developing next-generation biotechnology.
Start a ConsultationWe align cross-disciplinary teams around clear milestones, regulatory pathways, and reproducible experimental design.
From literature mining to data interpretation, we deliver structured analysis that accelerates decision-making.
We break complex innovation pipelines into manageable phases with defined deliverables and risk mitigation.
We turn complex scientific challenges into coordinated project frameworks — from experimental design to regulatory alignment.
Start a consultationConcrete outcomes from scientific coordination and analytical depth.
Structured project framing and clear milestones reduce review cycles by an average of 30%.
Early-stage scientific coordination cuts rework by identifying gaps before submission.
Analytical insight transforms raw results into compelling evidence for stakeholders and journals.
We bridge wet-lab, bioinformatics, and regulatory teams so everyone works from the same roadmap.
Contingency planning based on real project data keeps milestones achievable under uncertainty.
Modular SOPs and lab notebooks that grow with your research program, not against it.
Scope of consulting. Rivabiotec provides advisory services in biotechnology project structuring, analytical insight, and scientific coordination. Our recommendations are based on available data and current regulatory frameworks. We do not guarantee specific research outcomes, funding approvals, or commercial results.
Confidentiality. All client information shared during engagements is treated as confidential unless otherwise agreed in writing. Rivabiotec may anonymize and aggregate non-identifiable data for internal analysis or publication. Clients are responsible for ensuring they have the right to share any third-party materials.
Limitation of liability. Rivabiotec’s liability is limited to the fees paid for the specific service giving rise to a claim. We are not liable for indirect, consequential, or incidental damages, including loss of data, research delays, or missed opportunities. This does not affect statutory rights that cannot be excluded.
Intellectual property. Deliverables produced specifically for a client engagement remain the client’s property, provided all fees are paid. Rivabiotec retains the right to use general methodologies, frameworks, and know-how developed independently of client work. Clients should not assume any license to pre-existing Rivabiotec intellectual property.
Modifications. These terms may be updated to reflect changes in our services or applicable law. Continued use of our services after a revision constitutes acceptance of the updated terms. Material changes will be communicated via email or a notice on our website.
Governing law. Any disputes arising from these terms or our services shall be governed by the laws of the jurisdiction in which Rivabiotec is registered, without regard to conflict of law principles. Clients agree to submit to the exclusive jurisdiction of the courts in that location.
Clear answers about our consulting process and scientific support.
We work with early-stage biotech startups, academic labs, and corporate R&D teams. Our focus spans molecular diagnostics, synthetic biology, therapeutic development, and industrial biomanufacturing. We help structure projects from preclinical concept validation through to regulatory strategy.
We conduct a structured review of your experimental design, data pipelines, and literature landscape. Deliverables include a gap analysis, risk assessment, and a prioritized roadmap. Our reports are written for both scientific leads and non-specialist stakeholders, ensuring alignment across your team.
Yes. We assist with project structuring for grant submissions, including SBIR/STTR proposals, Horizon Europe calls, and foundation grants. Our team reviews the scientific narrative, budget justification, and milestone definitions to strengthen your application without overpromising results.
A standard consulting engagement lasts 4 to 8 weeks, depending on scope. We begin with a discovery phase (1–2 weeks), followed by analysis and reporting (2–4 weeks), and a close-out session with actionable recommendations. Longer-term scientific coordination retainers are also available for ongoing programs.
All client information is protected under a standard non-disclosure agreement. We do not retain any proprietary data after the engagement ends. Our consultants sign IP assignment clauses where required, and we never reuse client-specific protocols or datasets in other projects.